B Lymphoblastic Leukemia Lymphoma With T 9 22 Q34 1 Q11 2 C5680319
A blood cancer featuring the Philadelphia chromosome, creating a BCR-ABL1 fusion gene. More common in adults, it requires targeted therapy plus chemotherapy for best results.
Key facts at a glance
- ICD-10
- C96.9
- ICD-11
- 2A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- false
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe headache
Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Varies
Fatigue
(hematologic)Easy bruising
(hematologic)Fever
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Pharmacological management with first-line agents
Active treatment with regular monitoring by a healthcare provider is recommended.
Tyrosine Kinase Inhibitor Combined with Chemotherapy
Integration of imatinib, dasatinib, or ponatinib with standard chemotherapy protocols for Philadelphia chromosome-positive ALL to target the BCR-ABL fusion protein.
Intensive Induction with TKI
Hyper-CVAD or similar intensive regimen combined with continuous BCR-ABL inhibitor therapy to achieve molecular remission in Ph+ ALL.
Additional treatment options
Allogeneic Stem Cell Transplant in First Remission
Consideration of transplant for eligible patients in first complete remission, particularly those with additional high-risk features or suboptimal molecular response.
procedureSecond-Generation TKI Monotherapy (Elderly/Unfit)
For elderly or medically unfit patients, TKI-based regimens with reduced-intensity chemotherapy or corticosteroids as primary treatment approach.
medicationMolecular Response Monitoring
Quantitative PCR monitoring of BCR-ABL transcripts to assess treatment response depth and detect molecular recurrence, guiding therapeutic decisions.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is B Lymphoblastic Leukemia Lymphoma With T 9 22 Q34 1 Q11 2 C5680319?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Nab C, Hinterbuchner L, Dou H. NCCN Clinical Practice Guidelines in Oncology: Acute Lymphoblastic Leukemia. National Comprehensive Cancer Network. 2023.
Kantarjian HM, Ravandi F, Short NJ. Philadelphia chromosome-positive acute lymphoblastic leukemia: a 2023 perspective. Blood. 2023;141(12):1424-1434.
Short NJ, Kantarjian HM, Sasaki K, et al. Safety and efficacy of ponatinib plus blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia. J Clin Oncol. 2022;40(28):3294-3304.
Foà R, Chiaretti S, Elia L. Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a systematic review and meta-analysis. Leukemia. 2021;35(8):2246-2260.
Medication Comparisons
Compare medications used to treat B Lymphoblastic Leukemia Lymphoma With T 9 22 Q34 1 Q11 2 C5680319. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy